Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05522491
Status:
UNKNOWN
Last Update Posted:
2022-08-31
First Post:
2022-08-28
Brief Title:
Olaparib in the Treatment of BRCA12 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords: